{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:30:57Z","timestamp":1793370657092,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013700","name":"National Comprehensive Cancer Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007075","name":"European Society for Medical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijgc.2025.101668","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T16:41:07Z","timestamp":1738168867000},"page":"101668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Controversies in the management of ovarian granulosa cell and Sertoli-Leydig cell tumors"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3090-795X","authenticated-orcid":false,"given":"Michael L.","family":"Friedlander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9405-8195","authenticated-orcid":false,"given":"Lyndal","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2009-8263","authenticated-orcid":false,"given":"Yeh Chen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijgc.2025.101668_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/ijgc-2020-002018","article-title":"Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management","volume":"31","author":"Al Harbi","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.ijgc.2025.101668_bib2","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1200\/JOP.2016.016261","article-title":"Ovarian sex cord-stromal tumors","volume":"12","author":"Schultz","year":"2016","journal-title":"J Oncol Pract"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101668_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2013.10.013","article-title":"Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network","volume":"132","author":"Maillet","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ijgc.2025.101668_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw134","article-title":"Molecularly defined adult granulosa cell tumor of the ovary: the clinical phenotype","volume":"108","author":"McConechy","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"26","key":"10.1016\/j.ijgc.2025.101668_bib5","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1056\/NEJMoa0902542","article-title":"Mutation of FOXL2 in granulosa-cell tumors of the ovary","volume":"360","author":"Shah","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101668_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ygyno.2022.03.019","article-title":"Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG)","volume":"165","author":"Henno","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ijgc.2025.101668_bib7","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.5858\/arpa.2021-0385-OA","article-title":"Cystic granulosa cell tumors of the ovary: an analysis of 80 cases of an often diagnostically challenging entity","volume":"146","author":"Boyraz","year":"2022","journal-title":"Arch Pathol Lab Med."},{"issue":"12","key":"10.1016\/j.ijgc.2025.101668_bib8","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.5858\/arpa.2018-0291-RA","article-title":"Ovarian sex cord-stromal tumors: reflections on a 40-year experience with a fascinating group of tumors, including comments on the seminal observations of Robert E. Scully, MD","volume":"142","author":"Young","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101668_bib9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/PAS.0000000000002010","article-title":"Well-differentiated Sertoli-Leydig cell tumors (SLCTs) are not associated with DICER1 pathogenic variants and represent a different tumor type to moderately and poorly differentiated SLCTs","volume":"47","author":"McCluggage","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101668_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/bjc.2013.241","article-title":"Long-term follow-up is crucial after treatment for granulosa cell tumors of the ovary","volume":"109","author":"Mangili","year":"2013","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101668_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/IGC.0000000000000304","article-title":"Clinical characteristics and survival of patients with an adult-type ovarian granulosa cell tumor: a 56-year single-center experience","volume":"25","author":"Bryk","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101668_bib12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/ijgc-2022-003854","article-title":"Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence","volume":"33","author":"Plett","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.ijgc.2025.101668_bib13","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ejso.2021.02.003","article-title":"Stage I juvenile granulosa cell tumors of the ovary: a multicenter analysis from the MITO-9 study","volume":"47","author":"Bergamini","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"suppl 4","key":"10.1016\/j.ijgc.2025.101668_bib14","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/annonc\/mdy001","article-title":"Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Ray-Coquard","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijgc.2025.101668_bib15","series-title":"Ovarian Cancer\/Fallopian Tube Cancer\/Primary Peritoneal Cancer. version 2.2024","year":"2024"},{"key":"10.1016\/j.ijgc.2025.101668_bib16","article-title":"Adult granulosa cell tumors of the ovary: a retrospective study of 36 FIGO Stage I cases with emphasis on prognostic pathohistological features","volume":"2018","author":"Babarovi\u0107","year":"2018","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101668_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/ijgc-2018-000083","article-title":"Outcomes of fertility-sparing surgery in ovarian juvenile granulosa cell tumor","volume":"29","author":"Zhao","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.ijgc.2025.101668_bib18","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S1470-2045(20)30091-7","article-title":"ESGO-SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers","volume":"21","author":"Sessa","year":"2020","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101668_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ygyno.2021.08.012","article-title":"Clinicopathological characteristics and prognostic factors of ovarian granulosa cell tumors: a JSGO-JSOG joint study","volume":"163","author":"Ebina","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"suppl 4","key":"10.1016\/j.ijgc.2025.101668_bib20","article-title":"Consensus recommendations from the EXPeRT\/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents","volume":"68","author":"Schneider","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijgc.2025.101668_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2024.04.005","article-title":"Outcomes in ovarian Sertoli-Leydig cell tumor: a report from the International Pleuropulmonary Blastoma\/DICER1 and Ovarian and Testicular stromal Tumor Registries","volume":"186","author":"Nelson","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101668_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2014.12.026","article-title":"The role of systemic chemotherapy in the management of granulosa cell tumors","volume":"136","author":"Meisel","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2025.101668_bib23","article-title":"The prognostic significance of adjuvant chemotherapy in adult ovarian granulosa cell tumors: a systematic review and meta-analysis","volume":"30","author":"Zhuang","year":"2023","journal-title":"Cancer Control"},{"issue":"9","key":"10.1016\/j.ijgc.2025.101668_bib24","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.21873\/anticanres.13686","article-title":"Increased risk of breast and uterine cancer among women with ovarian granulosa cell tumors","volume":"39","author":"Nasioudis","year":"2019","journal-title":"Anticancer Res"},{"issue":"7","key":"10.1016\/j.ijgc.2025.101668_bib25","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/ijc.29532","article-title":"The clinical utility of serum anti-Mullerian hormone in the follow-up of ovarian adult-type granulosa cell tumors--a comparative study with inhibin B","volume":"137","author":"F\u00e4rkkil\u00e4","year":"2015","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101668_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ygyno.2006.12.034","article-title":"Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort","volume":"105","author":"Mom","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ijgc.2025.101668_bib27","first-page":"3495","article-title":"Adult-type granulosa cell tumor of the ovary","volume":"12","author":"Li","year":"2022","journal-title":"Am J Cancer Res"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101668_bib28","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101668_bib29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0002-9378(96)70333-2","article-title":"AntiMullerian hormone as a serum marker of granulosa cell tumorsof the ovary: comparative study with serum alpha-inhibin and estradiol","volume":"174","author":"Rey","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101668_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ygyno.2021.05.027","article-title":"FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring","volume":"162","author":"Groeneweg","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2025.101668_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2023.05.014","article-title":"Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salome study including 469 patients. A TMRG and GINECO group study","volume":"174","author":"Hanvic","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101668_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/healthcare7040145","article-title":"Clinical determinants affecting indications for surgery and chemotherapy in recurrent ovarian granulosa cell tumor","volume":"7","author":"Nakai","year":"2019","journal-title":"Healthcare (Basel)"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101668_bib33","doi-asserted-by":"crossref","first-page":"544.e1","DOI":"10.1016\/j.ajog.2024.01.002","article-title":"Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors","volume":"230","author":"How","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ijgc.2025.101668_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejogrb.2021.06.036","article-title":"Ovarian Sertoli-Leydig cell tumors: a systematic review of relapsed cases","volume":"263","author":"Nef","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101668_bib35","article-title":"Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumors of the ovary (primary and recurrent)","volume":"2014","author":"Gurumurthy","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101668_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006250-198602000-00020","article-title":"Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary","volume":"67","author":"Colombo","year":"1986","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101668_bib37","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0090-8258(82)90102-0","article-title":"Combination chemotherapy of ovarian granulosa cell tumor with cis-platinum and doxorubicin","volume":"14","author":"Jacobs","year":"1982","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ijgc.2025.101668_bib38","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0959-8049(99)00142-2","article-title":"Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumors of the ovary. An EORTC Gynaecological Cancer Cooperative Group study","volume":"35","author":"Pecorelli","year":"1999","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101668_bib39","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0029-7844(95)00491-2","article-title":"Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin","volume":"87","author":"Gershenson","year":"1996","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101668_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/gyno.1998.5304","article-title":"Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study","volume":"72","author":"Homesley","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"17","key":"10.1016\/j.ijgc.2025.101668_bib41","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1200\/JCO.2004.12.074","article-title":"The activity of taxanes in the treatment of sex cord-stromal ovarian tumors","volume":"22","author":"Brown","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101668_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2015.11.027","article-title":"A phase II study of paclitaxel for the treatment of ovarian stromal tumors: an NRG Oncology\/ Gynecologic Oncology Group Study","volume":"140","author":"Burton","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2025.101668_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2024.09.002","article-title":"Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: an NRG oncology\/gynecologic oncology group study14","volume":"190","author":"Brown","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101668_bib44","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejogrb.2013.06.041","article-title":"Results of oxaliplatin-based hyperthermic intraperitoneal chemotherapy in recurrent ovarian granulosa cell tumors","volume":"170","author":"Gouy","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"10","key":"10.1016\/j.ijgc.2025.101668_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28621","article-title":"Pediatric ovarian Sertoli-Leydig cell tumors with heterologous rhabdomyosarcoma elements: clinical case series and review of the literature","volume":"67","author":"Koo","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101668_bib46","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cncr.28421","article-title":"Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: results of a phase 2 trial of the Gynecologic Oncology Group","volume":"120","author":"Brown","year":"2014","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ijgc.2025.101668_bib47","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1001\/jamaoncol.2020.4574","article-title":"Effect of weekly paclitaxel with or without bevacizumab on progression-free rate among patients with relapsed ovarian sex cord-stromal tumors: the ALIENOR\/ENGOT-ov7 randomized clinical trial","volume":"6","author":"Ray-Coquard","year":"2020","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101668_bib48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/pgp.0b013e31805c0d99","article-title":"Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors","volume":"26","author":"Farinola","year":"2007","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101668_bib49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2014.03.573","article-title":"Hormone therapy in ovarian granulosa cell tumors: a systematic review","volume":"134","author":"van Meurs","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101668_bib50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ygyno.2021.07.024","article-title":"A phase 2 study of anastrozole in patients with estrogen receptor and\/progesterone receptor positive recurrent\/metastatic granulosa cell tumors\/sex-cord stromal tumors of the ovary: the Paragon\/ANZGOG 0903 trial","volume":"163","author":"Banerjee","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ijgc.2025.101668_bib51","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s12094-023-03085-w","article-title":"Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa et ketoconazole) trial, GETHI 2011\u201303","volume":"25","author":"Garcia-Donas","year":"2023","journal-title":"Clin Transl Oncol"},{"issue":"suppl 15","key":"10.1016\/j.ijgc.2025.101668_bib52","article-title":"Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: the Greko II study","volume":"35","author":"Garc\u00eda-Donas","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijgc.2025.101668_bib53","article-title":"A case series of triplet anti-hormonal therapy in androgen receptor-positive recurrent adult ovarian granulosa cell tumor","volume":"44","author":"Summey","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.ijgc.2025.101668_bib54","article-title":"Efficacy of cyclin-dependent kinase 4\/6 inhibitors in combination with hormonal therapy in patients with recurrent granulosa cell tumor of the ovary: a case series","volume":"50","author":"Albright","year":"2023","journal-title":"Gynecol Oncol Rep"}],"updated-by":[{"DOI":"10.1016\/j.ijgc.2025.101953","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000}}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25001938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25001938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T01:40:30Z","timestamp":1772329230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25001938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1048891X25001938"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.101668","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controversies in the management of ovarian granulosa cell and Sertoli-Leydig cell tumors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.101668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101668"}}